Enliven Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $64M | 2.7M | 23.37 |
| 2024-03-31 | $32M | 1.8M | 17.59 |
| 2023-09-30 | $21M | 1.6M | 13.66 |
| 2023-06-30 | $32M | 1.5M | 20.41 |
| 2023-03-31 | $740k | 34k | 21.88 |